| 低分子质量肝素治疗不稳定型冠状动脉疾病32例 |
| |
| 引用本文： | 苏延海,郭晋祥.低分子质量肝素治疗不稳定型冠状动脉疾病32例[J].河北医学,2003,9(10):920-922. |
| |
| 作者姓名： | 苏延海 郭晋祥 |
| |
| 作者单位： | 1. 江苏省建湖县裴刘医院,江苏,建湖,224712
2. 江苏省盐城市第一人民医院,江苏,盐城,224006 |
| |
| 摘 要： | 目的：探讨低分子肝素对急性冠脉综合征的疗效。方法：70例急性冠脉综合征患者随机分为二组，低分子肝素治疗组和普通肝素治疗组。结果：低分子肝素疗效优于普通肝素，且并发症少。结论：低分子肝素可作为常规用于急性冠脉综合征患者的早期干预治疗。
|
| 关 键 词： | 低分子肝素 普通肝素 急性冠脉综合征 |
| 文章编号： | 1006-6233(2003)10-0920-03 |
Effect of low molecular-weight heparin on patients with acute coronary syndrome |
| |
| SU Yan-hai,et al.Effect of low molecular-weight heparin on patients with acute coronary syndrome[J].Hebei Medicine,2003,9(10):920-922. |
| |
| Authors: | SU Yan-hai |
| |
| Abstract: | Objective: To investigate the effects of low molecular-weight heparin (LMWH) on patients with acute coronary syndrome (ACS). Method: ACS cases were randomized to two groups, one group was treated with low molecular-weight heparin(LMWH), the control group was treated with common heparin. Result: LMWH was better than common heparin in treating ACS patients, the complications of LMWH is less. Conclusion: LMWH may be used as an early intervensive method routinely in the treatment of ACS patients. |
| |
| Keywords: | Low molecular-weight heparin Common heparin Acute coronary syndrome |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
